Flucelvax - INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
Navigation: NDC > Supplier starting with: N > NOVARTIS VACCINES AND DIAGNOSTICS GMBH| Field | Value |
|---|---|
| NDC Code: | 63851-612 |
| Proprietary Name: | Flucelvax |
| Suffix: | |
| Non-Proprietary Name: | INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
| Dosage Form: | INJECTION, SUSPENSION |
| Method: | INTRAMUSCULAR |
| Original Marketing Date: | 30-08-2013 |
| Category Name: | BLA |
| Application Number: | BLA125408 |
| Labeler: | NOVARTIS VACCINES AND DIAGNOSTICS GMBH |
| Substance Name: | INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
| Active Numerator Strength: | 15; 15; 15 |
| Active Ingredient Unit: | ug/.5mL; ug/.5mL; ug/.5mL |
| Pharm Classes: | |
| DEA Schedule: |